Calamos Advisors LLC - MEDICINES CO ownership

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of MEDICINES CO
ValueSharesWeighting
Q4 2019$24,415,000
+43.6%
14,000,0000.0%0.12%
+30.1%
Q3 2019$17,008,000
+23.8%
14,000,0000.0%0.09%
+22.4%
Q2 2019$13,735,000
+16.9%
14,000,0000.0%0.08%
+4.1%
Q1 2019$11,754,000
+12.4%
14,000,0000.0%0.07%
+5.8%
Q4 2018$10,456,000
-25.0%
14,000,000
-8.2%
0.07%
-10.4%
Q3 2018$13,935,000
-9.0%
15,250,0000.0%0.08%
-18.1%
Q2 2018$15,321,000
+3.1%
15,250,0000.0%0.09%
-3.1%
Q1 2018$14,867,000
+6.0%
15,250,0000.0%0.10%
+36.6%
Q4 2017$14,025,000
-12.7%
15,250,0000.0%0.07%
-42.7%
Q3 2017$16,057,000
+0.1%
15,250,0000.0%0.12%
+4.2%
Q2 2017$16,036,00015,250,0000.12%
Other shareholders
MEDICINES CO shareholders Q3 2023
NameSharesValueWeighting ↓
Man Investments (CH) AG 3,000,000$2,762,0002.59%
PT ASSET MANAGEMENT, LLC 3,750,000$3,448,0001.87%
ARISTEIA CAPITAL, L.L.C. 32,500,000$29,921,0001.27%
ZAZOVE ASSOCIATES LLC 22,710,000$20,905,0001.23%
PFM Health Sciences, LP 34,471,000$31,692,0000.75%
CAPSTONE INVESTMENT ADVISORS, LLC 24,215,000$22,262,0000.63%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 36,000,000$33,075,000,0000.59%
Partner Investment Management, L.P. 479,000$440,0000.51%
SSI INVESTMENT MANAGEMENT LLC 4,808,000$4,398,0000.37%
WOLVERINE ASSET MANAGEMENT LLC 32,315,000$29,732,0000.30%
View complete list of MEDICINES CO shareholders